Invention Grant
- Patent Title: Method of treating diabetes type 2 by administering ultrarapid acting insulin
-
Application No.: US17105399Application Date: 2020-11-25
-
Publication No.: US11998591B2Publication Date: 2024-06-04
- Inventor: Peter Richardson , Robert A. Baughman , Elizabeth Potocka , Anders Hasager Boss , Richard Petrucci
- Applicant: MannKind Corporation
- Applicant Address: US CA Westlake Village
- Assignee: MannKind Corporation
- Current Assignee: MannKind Corporation
- Current Assignee Address: US CT Danbury
- Agency: K&L Gates LLP
- Agent Louis C. Cullman; Hal Gibson
- The original application number of the division: US14102383 2013.12.10
- Main IPC: A61K38/28
- IPC: A61K38/28 ; A61K9/00 ; A61K47/54
Abstract:
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.
Public/Granted literature
- US20210138040A1 METHOD OF TREATING DIABETES TYPE 2 BY ADMINISTERING ULTRARAPID ACTING INSULIN Public/Granted day:2021-05-13
Information query
IPC分类:
